Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 06 Sep 2024

The lncRNA CADM2-AS1 promotes gastric cancer metastasis by binding with miR-5047 and activating NOTCH4 translation

in Pharmacology of Anti-Cancer Drugs

Yu-Tong Zhang
Li-Juan Zhao
Teng Zhou
Jin-Yuan Zhao
Yin-Ping Geng
Qiu-Rong Zhang
Pei-Chun Sun
Wen-Chao Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1439497

1,474 views

Original Research

Published on 06 Sep 2024

Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study

in Pharmacology of Anti-Cancer Drugs

Hongxin Li
Wen Zhao
Caiyun Chang
Tiantian Xuan
Chengjun Wang
Rongyu Zhang
Chuang Yang
Jian Wang
Cuihua Yi
Xiuwen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1444707

1,990 views

Review

Published on 06 Sep 2024

Strategies for engineering oncolytic viruses to enhance cancer immunotherapy

in Pharmacology of Anti-Cancer Drugs

Ziyang (Steve) Yin
Zhengfeng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1450203

2,614 views
3 citations

Original Research

Published on 04 Sep 2024

PFKFB3 deprivation attenuates the cisplatin resistance via blocking its autophagic elimination in colorectal cancer cells

in Pharmacology of Anti-Cancer Drugs

Qianqian Li
Jianxing Ma
Yaqin Zhang
Fengyao Sun
Wen Li
Wenzhi Shen
Zhiying Ai
Changli Li
Shanshan Wang
Xiaonan Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1433137

1,793 views
1 citation

Case Report

Published on 04 Sep 2024

The efficacy of stereotactic radiotherapy followed by bevacizumab and temozolomide in the treatment of recurrent glioblastoma: a case report

in Pharmacology of Anti-Cancer Drugs

Wangyan Zhong
Jiwei Mao
Dongping Wu
Jianghua Peng
Wanli Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1401000

1,540 views
2 citations

Original Research

Published on 04 Sep 2024

Paulownin elicits anti-tumor effects by enhancing NK cell cytotoxicity through JNK pathway activation

in Pharmacology of Anti-Cancer Drugs

Eun Sun Park
Yo Sep Hwang
Hyung Won Ryu
Hyang Ran Yoon
Jong-Tae Kim
Jong-Seok Lim
Hee Jun Cho
Hee Gu Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1439079

1,769 views

Original Research

Published on 04 Sep 2024

FTO diversely influences sensitivity of neuroblastoma cells to various chemotherapeutic drugs

in Pharmacology of Anti-Cancer Drugs

Meizhen Lin
Zhongyan Hua
Zhijie Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1384141

1,487 views
3 citations

Review

Published on 03 Sep 2024

Antitumor properties of griseofulvin and its toxicity

in Pharmacology of Anti-Cancer Drugs

Nanqiong Yu
Yixiao Fu
Qingkui Fan
Li Lin
Zhifeng Ning
Dongze Leng
Meichun Hu
Tonghui She

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1459539

2,301 views
4 citations

Review

Published on 02 Sep 2024

Unveiling the contribution of tumor-associated macrophages in driving epithelial-mesenchymal transition: a review of mechanisms and therapeutic Strategies

in Pharmacology of Anti-Cancer Drugs

Yijia Zhang
Xiaofei Ding
Xue Zhang
Ye Li
Rui Xu
Hai-Jun Li
Daiying Zuo
Guang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1404687

3,182 views
5 citations

Case Report

Published on 30 Aug 2024

Acute generalized exanthematous pustulosis induced by icotinib: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Wei Yang
Jiayu Zhao
Jun Niu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1462430

1,271 views
1 citation

Original Research

Published on 30 Aug 2024

Ouabain-mediated downregulation of ALKBH5 and IGF2BP2 inhibits the malignant progression of DLBCL

in Pharmacology of Anti-Cancer Drugs

Yuxin Hong
Hehua Ma
Haoyi Yang
Yuning Zhu
Yuan Wei
Zhenzhen Xu
Yuwen Zhang
Dandan Jin
Zhiyou Chen
Wei Song

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1447830

2,000 views

Original Research

Published on 30 Aug 2024

Anatomical classification of advanced biliary tract cancer predicts programmed cell death protein 1 blockade efficacy

in Pharmacology of Anti-Cancer Drugs

Lingli Huang
Fang Wang
Fenghua Wang
Qi Jiang
Jinsheng Huang
Xujia Li
Guifang Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1375769

1,265 views

Review

Published on 29 Aug 2024

The m6A regulators in prostate cancer: molecular basis and clinical perspective

in Pharmacology of Anti-Cancer Drugs

Yu Cao
Man Jia
Chunyan Duan
Zhihui Yang
Bo Cheng
Ronghao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448872

1,564 views

Original Research

Published on 29 Aug 2024

Proteomic assessment of SKBR3/HER2+ breast cancer cellular response to Lapatinib and investigational Ipatasertib kinase inhibitors

in Pharmacology of Anti-Cancer Drugs

Arba Karcini
Nicole R. Mercier
Iulia M. Lazar

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413818

3,003 views
1 citation

Systematic Review

Published on 29 Aug 2024

The mechanisms and drug therapies of colorectal cancer and epigenetics: bibliometrics and visualized analysis

in Pharmacology of Anti-Cancer Drugs

Siyu Tian
Min Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466156

2,864 views
2 citations

Original Research

Published on 28 Aug 2024

Predicting the efficiency of chidamide in patients with angioimmunoblastic T-cell lymphoma using machine learning algorithm

in Pharmacology of Anti-Cancer Drugs

Chunlan Zhang
Juan Xu
Mingyu Gu
Yun Tang
Wenjiao Tang
Jie Wang
Qinyu Liu
Yunfan Yang
Xushu Zhong
Caigang Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1435284

1,385 views